Forecast: Healthcare Expenditure on Epidemiological Surveillance and Risk and Disease Control Programmes in the UK

The healthcare expenditure on epidemiological surveillance and risk and disease control programmes in the UK shows a consistent year-on-year decline from 2024 to 2028, starting at 639.18 million Euros in 2024 and decreasing to 635.21 million Euros by 2028. This trend indicates a slight annual contraction over the forecasted period. The anticipated compound annual growth rate (CAGR) for this five-year span illustrates an overall decreasing trajectory in budget allocation for these activities.

Future trends to watch for include:

• Potential shifts in public health policy that could redirect funding towards more innovative or urgent health surveillance methodologies.
• Impact of technological advancements in epidemiological tools, which might necessitate further investment to maintain efficacy and agility in disease control strategies.
• External factors such as pandemic outbreaks that could drastically reshape funding priorities and alter current forecasted trends.